News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,347 Results
Type
Article (53158)
Company Profile (97)
Press Release (628041)
Multimedia
Podcasts (199)
Webinars (26)
Section
Business (212530)
Career Advice (2878)
Deals (34338)
Drug Delivery (185)
Drug Development (78250)
Employer Resources (181)
FDA (16313)
Job Trends (15081)
News (320797)
Policy (32058)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (7)
Academia (2920)
Academic (1)
Accelerated approval (63)
ADA (49)
Adcomms (43)
Allergies (205)
Alliances (46456)
ALS (248)
Alzheimer's disease (2012)
Antibody-drug conjugate (ADC) (596)
Approvals (16738)
Artificial intelligence (829)
ASCO (330)
Autoimmune disease (387)
Automation (65)
Bankruptcy (340)
Best Places to Work (11592)
BIO (67)
Biologics (3)
BIOSECURE Act (23)
Biosimilars (262)
BioSpace Insights (168)
Biotechnology (72)
Bladder cancer (219)
Brain cancer (82)
Breast cancer (865)
Cancer (6814)
Cardiovascular disease (579)
Career advice (2454)
Career pathing (56)
CAR-T (390)
CDC (75)
Celiac Disease (2)
Cell therapy (1038)
Cervical cancer (59)
Clinical research (68827)
Collaboration (2417)
Commercialization (9)
Company closure (9)
Compensation (1639)
Complete response letters (116)
COVID-19 (2970)
CRISPR (121)
C-suite (1471)
Cystic fibrosis (163)
Data (9094)
Decentralized trials (3)
Denatured (56)
Depression (204)
Dermatology (122)
Diabetes (709)
Diagnostics (7210)
Digital health (66)
Diversity (14)
Diversity, equity & inclusion (45)
Drug discovery (426)
Drug pricing (240)
Drug shortages (39)
Duchenne muscular dystrophy (344)
Earnings (70839)
Editorial (82)
Employer branding (23)
Employer resources (165)
Events (94291)
Executive appointments (1289)
FDA (20604)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (24)
Frontotemporal dementia (36)
Funding (1971)
Gene editing (271)
Generative AI (75)
Gene therapy (840)
GLP-1 (1279)
Government (5103)
Grass and pollen (6)
Guidances (429)
Healthcare (19138)
Hematology (194)
HIV (109)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (128)
Immunology and inflammation (360)
Immuno-oncology (121)
Indications (234)
Infectious disease (3377)
Inflammatory bowel disease (235)
Inflation Reduction Act (16)
Influenza (152)
Intellectual property (345)
Interviews (534)
IPO (16146)
IRA (60)
Job creations (3729)
Job search strategy (2011)
JPM (71)
Kidney cancer (28)
Labor market (110)
Layoffs (673)
Leadership (58)
Legal (7143)
Licensing (13)
Liver cancer (109)
Longevity (37)
Lung cancer (923)
Lymphoma (502)
Machine learning (65)
Management (65)
Manufacturing (1319)
Marketing (14)
MASH (228)
Medical affairs (1)
Medical device (13334)
Medtech (13543)
Mergers & acquisitions (19620)
Metabolic disorders (1856)
mRNA (272)
Multiple sclerosis (216)
NASH (24)
Neurodegenerative disease (537)
Neuropsychiatric disorders (135)
Neuroscience (3847)
Neurotech (1)
NextGen: Class of 2026 (6724)
Non-profit (4709)
Now hiring (79)
Obesity (890)
Opinion (376)
Ovarian cancer (248)
Pain (300)
Pancreatic cancer (374)
Parkinson's disease (424)
Partnered (38)
Patents (704)
Patient recruitment (869)
Peanut (69)
People (63907)
Pharmaceutical (27)
Pharmacy benefit managers (37)
Phase 1 (21099)
Phase 2 (30306)
Phase 3 (23205)
Pipeline (11388)
Policy (400)
Postmarket research (2359)
Preclinical (8913)
Press Release (70)
Prostate cancer (354)
Psychedelics (84)
Radiopharmaceuticals (378)
Rare diseases (1364)
Real estate (5876)
Recruiting (77)
Regulatory (26325)
Reports (56)
Research institute (2638)
Resumes & cover letters (446)
Rett syndrome (51)
RNA editing (27)
RSV (99)
Schizophrenia (202)
Series A (334)
Series B (255)
Service/supplier (6)
Sickle cell disease (131)
Special edition (34)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (3549)
State (2)
Stomach cancer (19)
Supply chain (146)
Tariffs (104)
The Weekly (140)
Vaccines (1312)
Venture capital (144)
Weight loss (609)
Women's health (147)
Worklife (26)
Date
Today (94)
Last 7 days (421)
Last 30 days (2405)
Last 365 days (29946)
2026 (19736)
2025 (29560)
2024 (34141)
2023 (38757)
2022 (49698)
2021 (54010)
2020 (53201)
2019 (46813)
2018 (35569)
2017 (32680)
2016 (31432)
2015 (36028)
2014 (27295)
2013 (22606)
2012 (23911)
2011 (24650)
2010 (21653)
Location
Africa (918)
Alabama (103)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (42340)
Australia (7105)
California (13745)
Canada (4101)
China (1701)
Colorado (612)
Connecticut (620)
Delaware (442)
Europe (95867)
Florida (2184)
Georgia (442)
Hawaii (3)
Idaho (60)
Illinois (1156)
India (121)
Indiana (656)
Iowa (27)
Japan (645)
Kansas (140)
Kentucky (50)
Louisiana (58)
Maine (79)
Maryland (1626)
Massachusetts (9877)
Michigan (364)
Minnesota (724)
Mississippi (6)
Missouri (171)
Montana (35)
Nebraska (28)
Nevada (156)
New Hampshire (84)
New Jersey (3796)
New Mexico (34)
New York (3754)
North Carolina (1775)
North Dakota (11)
Northern California (6910)
Ohio (428)
Oklahoma (24)
Oregon (42)
Pennsylvania (2710)
Puerto Rico (33)
Rhode Island (51)
South America (1242)
South Carolina (90)
South Dakota (2)
Southern California (5593)
Tennessee (238)
Texas (2296)
United States (49211)
Utah (411)
Vermont (2)
Virginia (354)
Washington D.C. (79)
Washington State (1119)
West Virginia (4)
Wisconsin (153)
Wyoming (4)
681,347 Results for "juniper pharma formerly known as columbia laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026
·
2 min read
China
As pharma descends on China for deals, BIOSECURE Act raises intellectual property risk
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
July 28, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy
May 26, 2026
·
6 min read
Psychedelics
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
Eli Lilly’s proposed acquisition of AtaiBeckley is “the clearest strategic validation to date” of psychedelics as an emerging pharmaceutical category, according to H.C. Wainwright. The analyst cautioned, however, that the transaction should not be seen as “supporting a uniform re-rating of every psychedelic developer.”
July 20, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
August 3, 2026
·
8 min read
Press Releases
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
April 28, 2026
·
3 min read
Press Releases
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
August 2, 2026
·
9 min read
Press Releases
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer
July 6, 2026
·
4 min read
Press Releases
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
August 18, 2026
·
9 min read
Earnings
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
BridgeBio Pharma’s transthyretin amyloidosis medicine Attruby is off to a strong launch, while Alnylam lowered full-year sales guidance for competitor Amvuttra.
August 12, 2026
·
2 min read
·
Tristan Manalac
1 of 68,135
Next
